Alemtuzumab

CAS No. 216503-57-0

Alemtuzumab( —— )

Catalog No. M22150 CAS No. 216503-57-0

Alemtuzumab is a humanized monoclonal antibody against CD52 an antigen found on the surface of normal and malignant lymphocytes.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 629 In Stock
10MG 900 In Stock
25MG 1321 In Stock
50MG 1758 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Alemtuzumab
  • Note
    Research use only, not for human use.
  • Brief Description
    Alemtuzumab is a humanized monoclonal antibody against CD52 an antigen found on the surface of normal and malignant lymphocytes.
  • Description
    Alemtuzumab is a humanized monoclonal antibody against CD52 an antigen found on the surface of normal and malignant lymphocytes.
  • In Vitro
    ——
  • In Vivo
    Animal Model:hCD52 transgenic mice Dosage:0.5-5 mg/kg Administration:IP; a single dose Result:Resulted in the dose-dependent depletion of B and T lymphocytes in the peripheral blood and lymphoid organs.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Other Targets
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    216503-57-0
  • Formula Weight
    150 kDa
  • Molecular Formula
    ——
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ruck T, et al. Alemtuzumab in Multiple Sclerosis: Mechanism of Action and Beyond. Int J Mol Sci. 2015 Jul 20;16(7):16414-39.
molnova catalog
related products